Condition: Hereditary Cancer Syndromes · Sponsor: Weill Medical College of Cornell University
The investigators hypothesize that pregnancy and preconception care may be a feasible and effective time to offer inherited cancer risk screening. This study will assess interest in cancer genetic testing among patients receiving routine prenatal or preconception/fertility care. The goal is to evaluate the acceptability of BRCA1/2 testing when offered alongside standard prenatal genetic screening. The study will also explore whether universal screening in this population could support early cancer prevention and be cost-effective, especially among underserved populations.
This description comes directly from the study's public registry record.
Steve Lopez, BA · 9143127488 · stl4013@med.cornell.edu
Ravi Sharaf, MD, MS · 212-746-4014 · ras9030@med.cornell.edu
Always discuss trial participation with your own doctor first.
| Reproductive Medicine | Brooklyn, New York, United States | Recruiting |
| NewYork-Presbyterian Weill Cornell Medicine | Brooklyn, New York, United States | Not Yet Recruiting |
| Reproductive Medicine | New York, New York, United States | Recruiting |
| Weill Cornell Medicine | New York, New York, United States | Recruiting |
| NewYork-Presbyterian Weill Cornell Medicine Queens | Queens, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07052266